Top Markets
Coin of the day
NuGenerex Immuno-Oncology, Inc. NuGenerex Immuno-Oncology, Inc.

NuGenerex Immuno-Oncology, Inc.

NUGX
Peringkat dalam Saham #41797
NuGenerex Immuno-Oncology, Inc. is an oncology firm committed to treating... NuGenerex Immuno-Oncology, Inc. is an oncology firm committed to treating cancer through the strategic modulation of the immune system. The company's development pipeline includes a range of immunotherapeutic products and vaccines. Notably, it is advancing AE37, a peptide immunotherapeutic vaccine, which is currently undergoing Phase II clinical studies for metastatic triple-negative breast cancer. Founded in 1993 and headquartered in Miramar, Florida, the entity was formerly named Antigen Express, Inc. NuGenerex Immuno-Oncology, Inc. operates as a subsidiary of Generex Biotechnology Corporation.
Harga Saham
$0.0001
Terakhir disinkronkan: 2023-05-22
Kapitalisasi Pasar
$10.03K
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan NuGenerex Immuno-Oncology, Inc. (NUGX)

Kategori

Riwayat harga saham NuGenerex Immuno-Oncology, Inc. (NUGX)
Harga penutupan tertinggi: $0.00 pada 2023-05-01

Harga penutupan terendah: $1.44 pada 2021-03-01
Riwayat harga saham NuGenerex Immuno-Oncology, Inc. dari 2021 hingga 2026
Performa harga saham tahunan
Tahun Performa
2023 75.00%
2022 -98.81%
2021 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$527.87 33.33%
US
$873.57 35.10%
NL
$736.38 7.69%
CH
$263.09 18.09%
BE
$1.07K -7.34%
KR